Amazon.com, Inc. (AMZN) Builds a New Approach Towards Money

Amazon.com, Inc. (NASDAQ:AMZN) has been a fast growing entity during the last decade, acting as aggressively as a start-up would, but it seems that the company almost reached maturity and its next decisions are critical, suggested an interview with Thomas Giles on Bloomberg. According to sources, a new CFO might help the company keep the situation under control.
Amazon.com, Inc. (NASDAQ:AMZN)
Besides it’s e-commerce activities, Amazon.com, Inc. (NASDAQ:AMZN) managed to branch out into software, games, electronics and also cloud services.

“[...] Amazon is very much at the cross-roads. As they go deeper and deeper into cloud computing, for example, they are going into new things. They’re not judst an e-commerce company anymore, they are seller of hardware and consumer electronics looking more like an Apple,” stated Thomas Giles.

Amazon.com, Inc. (NASDAQ:AMZN) has also begun exploiting its influence in media and broadcasting. Disregarding the direction chosen for diversification, a stronger grip over company’s financial control is desired due to a larger amount of costs and revenues to be evaluated.

“[...] Their cash balance has grown from $4 billion in 2008 to $13 billion at the end of 2013, so huge advances in cash how much cash they have. They’re still nowhere near where Apple and Google are in terms of the amount of cash they have. But, increasingly you’ll have to take a look at what are we going to do with the cash. Is it all going to be reinvested? [...],” added Mr. Giles.

To welcome the change, Amazon.com, Inc. (NASDAQ:AMZN) will bring a new Chief Financial Officer to replace Tom Szkutak, who will retire next year. Brian Olsavsky will take charge of the company’s financial operations. In addition, sources predict a tighter policy over Amazon.com, Inc. (NASDAQ:AMZN)’s budget. The company has been eating up its profits just to gain market share and it might be time to take shareholders into account. It is difficult to comment upon the future of the company, because most of the results depend upon the implementation of the strategy chosen, not the method per se. However, investors might finally see dividends paid on their shares.

Disclosure: none

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!